Do nanoparticles have a future in dermal drug delivery?

Area of Science:

• Dermal drug delivery
• Nanotechnology
• Pharmacology

Background:

• Intact skin presents a significant barrier to nanoparticle penetration in vivo.
• Traditional topical substances often fail to reach viable skin layers.
• Nanoparticles may leverage the follicular pathway for enhanced dermal delivery.

Purpose of the Study:

• To investigate the potential of "smart" nanoparticles for dermal drug delivery.
• To compare three nanoparticle systems with distinct drug release trigger mechanisms.
• To evaluate nanoparticle penetration and drug translocation into the viable epidermis.

Main Methods:

• Comparison of three nanoparticle systems: BSA hydrogel, protease-triggered BSA, and IR-triggered AuNP-doped BSA.
• Assessment of drug release mechanisms: passive diffusion, enzymatic degradation, and photoactivation.
• Evaluation of follicular penetration depth and uptake by skin structures.

Main Results:

• All three nanoparticle systems demonstrated model drug release.
• BSA hydrogel nanoparticles showed limited follicular penetration, possibly due to agglomeration.
• Protease-triggered and IR-triggered nanoparticles achieved deep follicular penetration and sebaceous gland uptake.

Conclusions:

• Smart nanoparticles, engineered for triggered drug release, offer a viable future for dermal drug delivery.
• Targeted release within the hair follicle is key to overcoming skin barrier limitations.
• Nanoparticle design must consider factors like size and trigger mechanisms for optimal follicular delivery.